Rockefeller Financial Services’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,897
Closed -$70K 469
2016
Q4
$70K Sell
1,897
-2,494
-57% -$89.1K ﹤0.01% 402
2016
Q3
$152K Hold
4,391
﹤0.01% 323
2016
Q2
$143K Sell
4,391
-31
-0.7% -$950 ﹤0.01% 338
2016
Q1
$127K Sell
4,422
-4,454
-50% -$119K ﹤0.01% 351
2015
Q4
$297K Hold
8,876
0.01% 304
2015
Q3
$252K Buy
8,876
+2,022
+30% +$70.5K 0.01% 312
2015
Q2
$278K Buy
6,854
+1,456
+27% +$65.4K 0.01% 288
2015
Q1
$266K Buy
5,398
+5,367
+17,313% +$249K 0.01% 301
2014
Q4
$1K Buy
+31
New +$1.22K ﹤0.01% 471

Other funds holding AVNS

Rockefeller Financial Services's AVNS Position: Q1 2017 in Review

Rockefeller Financial Services sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 1,897 shares — an estimated $70K sold.

Rockefeller Financial Services first reported a position in AVNS in Q4 2014 and held it in 9 quarters. The position peaked at $297K in Q4 2015. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • Rockefeller Financial Services reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • Rockefeller Financial Services sold 1,897 Avanos Medical shares in Q1 2017, an estimated $70K.
  • Rockefeller Financial Services first reported a position in Avanos Medical in Q4 2014 and held it in 9 quarters.
  • Rockefeller Financial Services's Avanos Medical position peaked at $297K in Q4 2015.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Rockefeller Financial Services's 13F filing for Q1 2017, filed 28 Apr 2017.